Patents by Inventor Mehran Bashiri

Mehran Bashiri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6168592
    Abstract: This is an artificial occlusion kit for implanting and retaining an artificial occlusion device in a body space adjacent to and extending from a body lumen in a mammal. The includes at least one occlusion device and a retaining device for blocking the migration of the occlusion device out of the occlusion site. The retaining device is radially expandable at a retaining site adjacent the body space to be occluded to a diameter that is sufficient to engage the body lumen wall at the retaining site and form a barrier across the entrance zone of the body space to be occluded. The expanded retaining device also forms a lumen for flow through body lumen at the retaining site. At least one semi-penetrable space may also be provided in the retaining device, allowing introduction of occlusion devices into the body space to be occluded, but preventing subsequent migration of the occlusion devices out of the body space.
    Type: Grant
    Filed: April 23, 1999
    Date of Patent: January 2, 2001
    Assignee: Target Therapeutics, Inc.
    Inventors: David Kupiecki, Clifford Teoh, Hong Doan, Son M. Gia, Erik T. Engelson, Uriel Hiram Chee, Mehran Bashiri, Joseph C. Eder
  • Patent number: 6165178
    Abstract: This is an implant for placement in the human body and an assembly for so placing that implant. Most desirably, it is an implant for use in the vasculature of the human body and is used to occlude some space in that vasculature as a portion of a treatment regimen. The implant itself is preferably a component of a deployment device using an electrolytically severable joint. The implant is electrically isolated from the electrolytically severable joint by a highly resistive or insulative layer. Such isolation and minimization of the conductive pathway from the placement apparatus to the body's fluids appears to enhance the susceptibility of the electrolytic joint to quick erosion and detachment of the implant from the deployment media. Although the implant itself is preferably a vaso-occlusive device, it may instead be a stent, a vena cava filter, or other implant which may be installed in this manner.
    Type: Grant
    Filed: September 1, 1998
    Date of Patent: December 26, 2000
    Assignee: SCIMED Life Systems, Inc.
    Inventors: Mehran Bashiri, Michael P. Wallace, Pete Phong Pham, Cong Thach, Chad C. Roue, Joseph C. Eder, Erik T. Engelson
  • Patent number: 6156061
    Abstract: This is an implant for placement in the human body and an assembly for so placing that implant. Most desirably, it is an implant for use in the vasculature of the human body and is used to occlude some space in that vasculature as a portion of a treatment regimen. The implant itself is preferably a component of a deployment device using an electrolytically severable joint. The implant component is at least partially covered with a highly resistive or insulative covering. The highly resistive or insulative layer or covering appears to enhance the susceptibility of the electrolytic joint to quick erosion and thus detachment of the implant. Although the implant itself is preferably a vaso-occlusive device, it may instead be a stent, a vena cava filter, or other implant which may be installed in this manner. The implant may be independently coated with insulative or resistive material or may be formed using a material with such as tantalum, which forms such an insulator or resistor in situ.
    Type: Grant
    Filed: August 29, 1997
    Date of Patent: December 5, 2000
    Assignee: Target Therapeutics, Inc.
    Inventors: Michael P. Wallace, Mehran Bashiri, Chad C. Roue
  • Patent number: 6096034
    Abstract: This is an artificial occlusion kit for implanting and retaining an artificial occlusion device in a body space adjacent to and extending from a body lumen in a mammal. The includes at least one occlusion device and a retaining device for blocking the migration of the occlusion device out of the occlusion site. The retaining device is radially expandable at a retaining site adjacent the body space to be occluded to a diameter that is sufficient to engage the body lumen wall at the retaining site and form a barrier across the entrance zone of the body space to be occluded. The expanded retaining device also forms a lumen for flow through body lumen at the retaining site. The retaining device may be placed in the body temporarily or permanently. At least one semi-penetrable space may also be provided in the retaining device, allowing introduction of occlusion devices into the body space to be occluded, but preventing subsequent migration of the occlusion devices out of the body space.
    Type: Grant
    Filed: June 12, 1998
    Date of Patent: August 1, 2000
    Assignee: Target Therapeutics, Inc.
    Inventors: David Kupiecki, Clifford Teoh, Hong Doan, Son M. Gia, Erik T. Engelson, Uriel Hiram Chee, Mehran Bashiri, Joseph C. Eder
  • Patent number: 5984929
    Abstract: This is an implant for placement in the human body and an assembly for so placing that implant. Most desirably, it is an implant for use in the vasculature of the human body and is used to occlude some space in that vasculature as a portion of a treatment regimen. The implant itself is preferably a component of a deployment device using an electrolytically severable joint. The implant is electrically isolated from the electrolytically severable joint by a highly resistive or insulative layer. Such isolation and minimization of the conductive pathway from the placement apparatus to the body's fluids appears to enhance the susceptibility of the electrolytic joint to quick erosion and detachment of the implant from the deployment media. Although the implant itself is preferably a vaso-occlusive device, it may instead be a stent, a vena cava filter, or other implant which may be installed in this manner.
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: November 16, 1999
    Assignee: Target Therapeutics, Inc.
    Inventors: Mehran Bashiri, Michael P. Wallace, Pete Phong Pham, Cong Thach, Chad C. Roue, Erik T. Engelson
  • Patent number: 5980514
    Abstract: This is an artificial occlusion kit for implanting and retaining an artificial occlusion device in a body space adjacent to and extending from a body lumen in a mammal. The includes at least one occlusion device and a retaining device for blocking the migration of the occlusion device out of the occlusion site. The retaining device is radially expandable at a retaining site adjacent the body space to be occluded to a diameter that is sufficient to engage the body lumen wall at the retaining site and form a barrier across the entrance zone of the body space to be occluded. The expanded retaining device also forms a lumen for flow through body lumen at the retaining site. At least one semi-penetrable space may also be provided in the retaining device, allowing introduction of occlusion devices into the body space to be occluded, but preventing subsequent migration of the occlusion devices out of the body space.
    Type: Grant
    Filed: July 26, 1996
    Date of Patent: November 9, 1999
    Assignee: Target Therapeutics, Inc.
    Inventors: David Kupiecki, Clifford Teoh, Hong Doan, Son M. Gia, Erik T. Engelson, Uriel Hiram Chee, Mehran Bashiri, Joseph C. Eder
  • Patent number: 5868754
    Abstract: This is a device for capturing and removing bodies or articles from within a vessel, such vessels as may be found in the vascular system or the genital urinary tract. It includes a core wire which has attached at its distal end a plurality of fibers. The core wire may be introduced through a catheter to a selected site and further advanced and "twirled" to engage the offending foreign body. The retriever and its targeted foreign body are then withdrawn using the catheter.
    Type: Grant
    Filed: June 12, 1996
    Date of Patent: February 9, 1999
    Assignee: Target Therapeutics, Inc.
    Inventors: Marc-Alan Levine, Son M. Gia, Mehran Bashiri, David Kupiecki